-
Je něco špatně v tomto záznamu ?
Total intracranial hemorrhage volume measurement summating all compartments best in traumatic and nontraumatic intracranial bleeding
M. Horn, A. Banerjee, L. Kasickova, O. Volny, HS. Choi, F. Letteri, T. Ohara, K. Tanaka, S. Connolly, P. Ladenvall, M. Crowther, J. Beyer-Westendorf, A. Shoamanesh, AM. Demchuk, AS. Al Sultan, ANNEXa‐4 Investigators
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, randomizované kontrolované studie
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-09-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-09-01
Psychology Database (ProQuest)
od 2011-09-01
Wiley-Blackwell Open Access Titles
od 2011
PubMed
38680018
DOI
10.1002/brb3.3481
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- faktor Xa * MeSH
- inhibitory faktoru Xa aplikace a dávkování terapeutické užití MeSH
- intrakraniální krvácení * MeSH
- lidé středního věku MeSH
- lidé MeSH
- mozek diagnostické zobrazování MeSH
- rekombinantní proteiny aplikace a dávkování MeSH
- reprodukovatelnost výsledků MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
BACKGROUND AND PURPOSE: The ANNEXA-4 trial measured hemostatic efficacy of andexanet alfa in patients with major bleeding taking factor Xa inhibitors. A proportion of this was traumatic and nontraumatic intracranial bleeding. Different measurements were applied in the trial including volumetrics to assess for intracranial bleeding depending on the compartment involved. We aimed to determine the most reliable way to measure intracranial hemorrhage (ICrH) volume by comparing individual brain compartment and total ICrH volume. METHODS: Thirty patients were randomly selected from the ANNEXA-4 database to assess measurement of ICrH volume by compartment and in total. Total and compartmental hemorrhage volumes were measured by five readers using Quantomo software. Each reader measured baseline hemorrhage volumes twice separated by 1 week. Twenty-eight different ANNEXA-4 subjects were also randomly selected to assess intra-rater reliability of total ICrH volume measurement change at baseline and 12-h follow up, performed by three readers twice to assess hemostatic efficacy categories used in ANNEXA-4. RESULTS: Compartmental minimal detectable change percentages (MDC%) ranged between 9.72 and 224.13, with the greatest measurement error occurring in patients with a subdural hemorrhage. Total ICrH volume measurements had the lowest MDC%, which ranged between 6.57 and 33.52 depending on the reader. CONCLUSION: Measurement of total ICrH volumes is more accurate than volume by compartment with less measurement error. Determination of hemostatic efficacy was consistent across readers, and within the same reader, as well as when compared to consensus read. Volumetric analysis of intracranial hemostatic efficacy is feasible and reliable when using total ICrH volumes.
Biopharmaceuticals R and D AstraZeneca Mölndal Sweden
Department of Clinical Neurosciences University of Calgary Calgary Canada
Department of Medicine Division of Neurology Royal Columbian Hospital New Westminster Canada
Department of Medicine Division of Neurology University of Alberta Edmonton Canada
Department of Medicine McMaster University Hamilton Ontario Canada
Department of Neurology Kyoto Prefectural University of Medicine Kyoto Japan
Department of Neurology University Hospital Ostrava Ostrava Czech Republic
Department of Radiology Seoul Medical Center Seoul South Korea
Department of Radiology University of Calgary Calgary Canada
Faculty of Medicine Masaryk University Brno Czech Republic
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
Unit of Neurology San Jacopo Hospital Pistoia Italy
University Hospital Carl Gustav Carus Dresden Dresden Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014062
- 003
- CZ-PrNML
- 005
- 20240905134246.0
- 007
- ta
- 008
- 240725s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/brb3.3481 $2 doi
- 035 __
- $a (PubMed)38680018
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Horn, MacKenzie $u Department of Clinical Neurosciences, University of Calgary, Calgary, Canada $u Department of Radiology, University of Calgary, Calgary, Canada
- 245 10
- $a Total intracranial hemorrhage volume measurement summating all compartments best in traumatic and nontraumatic intracranial bleeding / $c M. Horn, A. Banerjee, L. Kasickova, O. Volny, HS. Choi, F. Letteri, T. Ohara, K. Tanaka, S. Connolly, P. Ladenvall, M. Crowther, J. Beyer-Westendorf, A. Shoamanesh, AM. Demchuk, AS. Al Sultan, ANNEXa‐4 Investigators
- 520 9_
- $a BACKGROUND AND PURPOSE: The ANNEXA-4 trial measured hemostatic efficacy of andexanet alfa in patients with major bleeding taking factor Xa inhibitors. A proportion of this was traumatic and nontraumatic intracranial bleeding. Different measurements were applied in the trial including volumetrics to assess for intracranial bleeding depending on the compartment involved. We aimed to determine the most reliable way to measure intracranial hemorrhage (ICrH) volume by comparing individual brain compartment and total ICrH volume. METHODS: Thirty patients were randomly selected from the ANNEXA-4 database to assess measurement of ICrH volume by compartment and in total. Total and compartmental hemorrhage volumes were measured by five readers using Quantomo software. Each reader measured baseline hemorrhage volumes twice separated by 1 week. Twenty-eight different ANNEXA-4 subjects were also randomly selected to assess intra-rater reliability of total ICrH volume measurement change at baseline and 12-h follow up, performed by three readers twice to assess hemostatic efficacy categories used in ANNEXA-4. RESULTS: Compartmental minimal detectable change percentages (MDC%) ranged between 9.72 and 224.13, with the greatest measurement error occurring in patients with a subdural hemorrhage. Total ICrH volume measurements had the lowest MDC%, which ranged between 6.57 and 33.52 depending on the reader. CONCLUSION: Measurement of total ICrH volumes is more accurate than volume by compartment with less measurement error. Determination of hemostatic efficacy was consistent across readers, and within the same reader, as well as when compared to consensus read. Volumetric analysis of intracranial hemostatic efficacy is feasible and reliable when using total ICrH volumes.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a intrakraniální krvácení $7 D020300
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a rekombinantní proteiny $x aplikace a dávkování $7 D011994
- 650 _2
- $a inhibitory faktoru Xa $x aplikace a dávkování $x terapeutické užití $7 D065427
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a mozek $x diagnostické zobrazování $7 D001921
- 650 12
- $a faktor Xa $7 D015951
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Banerjee, Ankur $u Department of Medicine, Division of Neurology, University of Alberta, Edmonton, Canada $1 https://orcid.org/0000000251854749
- 700 1_
- $a Kasickova, Linda $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Volny, Ondrej $u Department of Neurology, University Hospital Ostrava, Ostrava, Czech Republic $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u International Clinical Research Center (ICRC), St. Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Choi, Hyun Seok $u Department of Radiology, Seoul Medical Center, Seoul, South Korea
- 700 1_
- $a Letteri, Federica $u Unit of Neurology, San Jacopo Hospital, Pistoia, Italy
- 700 1_
- $a Ohara, Tomoyuki $u Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan
- 700 1_
- $a Tanaka, Koji $u Department of Clinical Neurosciences, University of Calgary, Calgary, Canada
- 700 1_
- $a Connolly, Stuart $u Department of Medicine, McMaster University, Hamilton, Ontario, Canada
- 700 1_
- $a Ladenvall, Per $u Biopharmaceuticals R&D, AstraZeneca, Mölndal, Sweden
- 700 1_
- $a Crowther, Mark $u Department of Medicine, McMaster University, Hamilton, Ontario, Canada
- 700 1_
- $a Beyer-Westendorf, Jan $u University Hospital Carl Gustav Carus Dresden, Dresden, Germany
- 700 1_
- $a Shoamanesh, Ashkan $u Department of Medicine, McMaster University, Hamilton, Ontario, Canada
- 700 1_
- $a Demchuk, Andrew M $u Department of Clinical Neurosciences, University of Calgary, Calgary, Canada $u Department of Radiology, University of Calgary, Calgary, Canada
- 700 1_
- $a Al Sultan, Abdulaziz S $u Department of Medicine, Division of Neurology, Royal Columbian Hospital, New Westminster, Canada $1 https://orcid.org/0000000328495386
- 710 2_
- $a ANNEXa‐4 Investigators
- 773 0_
- $w MED00188000 $t Brain and behavior $x 2162-3279 $g Roč. 14, č. 5 (2024), s. e3481
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38680018 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905134240 $b ABA008
- 999 __
- $a ok $b bmc $g 2143691 $s 1225928
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 14 $c 5 $d e3481 $e - $i 2162-3279 $m Brain and behavior $n Brain Behav $x MED00188000
- LZP __
- $a Pubmed-20240725